Unser Team

A dedicated, cross-disciplinary team of experts in medicine, molecular biology, biotechnology, and bioinformatics works in synergy to advance non-invasive early detection of prostate cancer and refine risk stratification at initial diagnosis, ensuring optimal treatment decisions for patients.